EIF2A expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 8.594600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
9.274600E-01
Normal-vs-Stage2
8.323000E-01
Normal-vs-Stage3
1.297830E-01
Normal-vs-Stage4
9.131800E-02
Stage1-vs-Stage2
8.403200E-01
Stage1-vs-Stage3
1.684030E-01
Stage1-vs-Stage4
3.816000E-02
Stage2-vs-Stage3
1.694230E-01
Stage2-vs-Stage4
7.104100E-03
Stage3-vs-Stage4
1.919640E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
8.598400E-01
Normal-vs-AfricanAmerican
6.389600E-01
Normal-vs-Asian
6.025800E-01
Caucasian-vs-AfricanAmerican
7.374000E-01
Caucasian-vs-Asian
2.334200E-01
AfricanAmerican-vs-Asian
2.446600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
8.541200E-01
Normal-vs-Female
8.679600E-01
Male-vs-Female
8.795000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
1.460250E-02
Normal-vs-Age(41-60Yrs)
6.528000E-01
Normal-vs-Age(61-80Yrs)
9.805000E-01
Normal-vs-Age(81-100Yrs)
6.717600E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
1.01590000001206E-06
Age(21-40Yrs)-vs-Age(61-80Yrs)
4.49350000000237E-05
Age(21-40Yrs)-vs-Age(81-100Yrs)
2.712200E-02
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.273560E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
9.124400E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
3.487200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
8.985400E-01
Normal-vs-Daily Drinker
7.157600E-01
Normal-vs-Weekly Drinker
6.603000E-01
Normal-vs-Occasional Drinker
3.541000E-01
Normal-vs-Social Drinker
7.962800E-01
Non Drinker-vs-Daily Drinker
5.796400E-01
Non Drinker-vs-Weekly Drinker
5.902800E-01
Non Drinker-vs-Occasional Drinker
1.943850E-02
Non Drinker-vs-Social Drinker
4.793800E-01
Daily Drinker-vs-Weekly Drinker
9.829400E-01
Daily Drinker-vs-Occasional Drinker
1.423670E-02
Daily Drinker-vs-Social Drinker
2.753600E-01
Weekly Drinker-vs-Occasional Drinker
2.393700E-02
Weekly Drinker-vs-Social Drinker
2.664600E-01
Occasional Drinker-vs-Social Drinker
1.510050E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
3.108200E-02
Normal-vs-Grade 2
7.083600E-03
Normal-vs-Grade 3
1.483740E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
3.337000E-03
Grade 1-vs-Grade 3
6.585100E-04
Grade 1-vs-Grade 4
3.108200E-02
Grade 2-vs-Grade 3
2.625000E-01
Grade 2-vs-Grade 4
7.083600E-03
Grade 3-vs-Grade 4
1.483740E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
9.636800E-01
Normal-vs-NonDiabetic
9.174000E-01
Diabetic-vs-NonDiabetic
6.404400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
8.265800E-01
Normal-vs-NoPancreatitis
8.997800E-01
Pancreatitis-vs-NoPancreatitis
4.347600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
7.975800E-01
Normal-vs-N1
8.531400E-01
N0-vs-N1
8.105000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
3.130000E-01
Normal-vs-TP53-NonMutant
8.489800E-01
TP53-Mutant-vs-TP53-NonMutant
1.781400E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
